BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 30340609)

  • 1. Untargeted lipidomic features associated with colorectal cancer in a prospective cohort.
    Perttula K; Schiffman C; Edmands WMB; Petrick L; Grigoryan H; Cai X; Gunter MJ; Naccarati A; Polidoro S; Dudoit S; Vineis P; Rappaport SM
    BMC Cancer; 2018 Oct; 18(1):996. PubMed ID: 30340609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolomic Profiling Identified Serum Metabolite Biomarkers and Related Metabolic Pathways of Colorectal Cancer.
    Zhang C; Zhou S; Chang H; Zhuang F; Shi Y; Chang L; Ai W; Du J; Liu W; Liu H; Zhou X; Wang Z; Hong T
    Dis Markers; 2021; 2021():6858809. PubMed ID: 34917201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced levels of hydroxylated, polyunsaturated ultra long-chain fatty acids in the serum of colorectal cancer patients: implications for early screening and detection.
    Ritchie SA; Ahiahonu PW; Jayasinghe D; Heath D; Liu J; Lu Y; Jin W; Kavianpour A; Yamazaki Y; Khan AM; Hossain M; Su-Myat KK; Wood PL; Krenitsky K; Takemasa I; Miyake M; Sekimoto M; Monden M; Matsubara H; Nomura F; Goodenowe DB
    BMC Med; 2010 Feb; 8():13. PubMed ID: 20156336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specificity of metabolic colorectal cancer biomarkers in serum through effect size.
    Di Giovanni N; Meuwis MA; Louis E; Focant JF
    Metabolomics; 2020 Aug; 16(8):88. PubMed ID: 32789702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a Correlative Strategy To Discover Colorectal Tumor Tissue Derived Metabolite Biomarkers in Plasma Using Untargeted Metabolomics.
    Wang Z; Cui B; Zhang F; Yang Y; Shen X; Li Z; Zhao W; Zhang Y; Deng K; Rong Z; Yang K; Yu X; Li K; Han P; Zhu ZJ
    Anal Chem; 2019 Feb; 91(3):2401-2408. PubMed ID: 30580524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UHPLC-HRMS-based Multiomics to Explore the Potential Mechanisms and Biomarkers for Colorectal Cancer.
    Wang X; Guan X; Tong Y; Liang Y; Huang Z; Wen M; Luo J; Chen H; Yang S; She Z; Wei Z; Zhou Y; Qi Y; Zhu P; Nong Y; Zhang Q
    BMC Cancer; 2024 May; 24(1):644. PubMed ID: 38802800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating Ultra-long-Chain Fatty Acids as Biomarkers of Colorectal Cancer Risk.
    Perttula K; Edmands WM; Grigoryan H; Cai X; Iavarone AT; Gunter MJ; Naccarati A; Polidoro S; Hubbard A; Vineis P; Rappaport SM
    Cancer Epidemiol Biomarkers Prev; 2016 Aug; 25(8):1216-23. PubMed ID: 27257090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarker patterns of inflammatory and metabolic pathways are associated with risk of colorectal cancer: results from the European Prospective Investigation into Cancer and Nutrition (EPIC).
    Aleksandrova K; Jenab M; Bueno-de-Mesquita HB; Fedirko V; Kaaks R; Lukanova A; van Duijnhoven FJ; Jansen E; Rinaldi S; Romieu I; Ferrari P; Murphy N; Gunter MJ; Riboli E; Westhpal S; Overvad K; Tjønneland A; Halkjær J; Boutron-Ruault MC; Dossus L; Racine A; Trichopoulou A; Bamia C; Orfanos P; Agnoli C; Palli D; Panico S; Tumino R; Vineis P; Peeters PH; Duell EJ; Molina-Montes E; Quirós JR; Dorronsoro M; Chirlaque MD; Barricarte A; Ljuslinder I; Palmqvist R; Travis RC; Khaw KT; Wareham N; Pischon T; Boeing H
    Eur J Epidemiol; 2014 Apr; 29(4):261-75. PubMed ID: 24791703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploratory metabolomic study to identify blood-based biomarkers as a potential screen for colorectal cancer.
    Asante I; Pei H; Zhou E; Liu S; Chui D; Yoo E; Conti DV; Louie SG
    Mol Omics; 2019 Feb; 15(1):21-29. PubMed ID: 30515501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma clusterin as a candidate pre-diagnosis marker of colorectal cancer risk in the Florence cohort of the European Prospective Investigation into Cancer and Nutrition: a pilot study.
    Bertuzzi M; Marelli C; Bagnati R; Colombi A; Fanelli R; Saieva C; Ceroti M; Bendinelli B; Caini S; Airoldi L; Palli D
    BMC Cancer; 2015 Feb; 15():56. PubMed ID: 25884309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A validated metabolomic signature for colorectal cancer: exploration of the clinical value of metabolomics.
    Farshidfar F; Weljie AM; Kopciuk KA; Hilsden R; McGregor SE; Buie WD; MacLean A; Vogel HJ; Bathe OF
    Br J Cancer; 2016 Sep; 115(7):848-57. PubMed ID: 27560555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selenium status is associated with colorectal cancer risk in the European prospective investigation of cancer and nutrition cohort.
    Hughes DJ; Fedirko V; Jenab M; Schomburg L; Méplan C; Freisling H; Bueno-de-Mesquita HB; Hybsier S; Becker NP; Czuban M; Tjønneland A; Outzen M; Boutron-Ruault MC; Racine A; Bastide N; Kühn T; Kaaks R; Trichopoulos D; Trichopoulou A; Lagiou P; Panico S; Peeters PH; Weiderpass E; Skeie G; Dagrun E; Chirlaque MD; Sánchez MJ; Ardanaz E; Ljuslinder I; Wennberg M; Bradbury KE; Vineis P; Naccarati A; Palli D; Boeing H; Overvad K; Dorronsoro M; Jakszyn P; Cross AJ; Quirós JR; Stepien M; Kong SY; Duarte-Salles T; Riboli E; Hesketh JE
    Int J Cancer; 2015 Mar; 136(5):1149-61. PubMed ID: 25042282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic perturbations prior to hepatocellular carcinoma diagnosis: Findings from a prospective observational cohort study.
    Stepien M; Keski-Rahkonen P; Kiss A; Robinot N; Duarte-Salles T; Murphy N; Perlemuter G; Viallon V; Tjønneland A; Rostgaard-Hansen AL; Dahm CC; Overvad K; Boutron-Ruault MC; Mancini FR; Mahamat-Saleh Y; Aleksandrova K; Kaaks R; Kühn T; Trichopoulou A; Karakatsani A; Panico S; Tumino R; Palli D; Tagliabue G; Naccarati A; Vermeulen RCH; Bueno-de-Mesquita HB; Weiderpass E; Skeie G; Ramón Quirós J; Ardanaz E; Mokoroa O; Sala N; Sánchez MJ; Huerta JM; Winkvist A; Harlid S; Ohlsson B; Sjöberg K; Schmidt JA; Wareham N; Khaw KT; Ferrari P; Rothwell JA; Gunter M; Riboli E; Scalbert A; Jenab M
    Int J Cancer; 2021 Feb; 148(3):609-625. PubMed ID: 32734650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabonomics identifies serum metabolite markers of colorectal cancer.
    Tan B; Qiu Y; Zou X; Chen T; Xie G; Cheng Y; Dong T; Zhao L; Feng B; Hu X; Xu LX; Zhao A; Zhang M; Cai G; Cai S; Zhou Z; Zheng M; Zhang Y; Jia W
    J Proteome Res; 2013 Jun; 12(6):3000-9. PubMed ID: 23675754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum microRNA signatures and metabolomics have high diagnostic value in colorectal cancer using two novel methods.
    Liu HN; Liu TT; Wu H; Chen YJ; Tseng YJ; Yao C; Weng SQ; Dong L; Shen XZ
    Cancer Sci; 2018 Apr; 109(4):1185-1194. PubMed ID: 29363233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Integrated analysis of serum untargeted metabolomics and targeted bile acid metabolomics for identification of diagnostic biomarkers for colorectal cancer].
    Wang X; Zhu Y; Zhou H; Huang Z; Chen H; Zhang J; Yang S; Chen G; Zhang Q
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 Mar; 43(3):443-453. PubMed ID: 37087590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic phenotyping to monitor chronic enteritis canceration.
    Zhang F; Li C; Deng K; Wang Z; Zhao W; Yang K; Yang C; Rong Z; Cao L; Lu Y; Huang Y; Han P; Li K
    Metabolomics; 2020 Feb; 16(3):29. PubMed ID: 32095917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A quantitative multimodal metabolomic assay for colorectal cancer.
    Farshidfar F; Kopciuk KA; Hilsden R; McGregor SE; Mazurak VC; Buie WD; MacLean A; Vogel HJ; Bathe OF
    BMC Cancer; 2018 Jan; 18(1):26. PubMed ID: 29301511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Proteomic Technologies for Blood-Based Detection of Colorectal Cancer.
    Bhardwaj M; Terzer T; Schrotz-King P; Brenner H
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33530402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective study of the immune system activation biomarker neopterin and colorectal cancer risk.
    Aleksandrova K; Chuang SC; Boeing H; Zuo H; Tell GS; Pischon T; Jenab M; Bueno-de-Mesquita B; Vollset SE; Midttun Ø; Ueland PM; Fedirko V; Johansson M; Weiderpass E; Severi G; Racine A; Boutron-Ruault MC; Kaaks R; Kühn T; Tjønneland A; Overvad K; Quirós JR; Jakszyn P; Sánchez MJ; Dorronsoro M; Chirlaque MD; Ardanaz E; Khaw KT; Wareham NJ; Travis RC; Trichopoulou A; Lagiou P; Trichopoulos D; Palli D; Sieri S; Tumino R; Panico S; May AM; Palmqvist R; Ljuslinder I; Kong SY; Freisling H; Gunter MJ; Lu Y; Cross AJ; Riboli E; Vineis P
    J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25713165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.